CTOs on the Move

Viatris

www.viatris.com

 
VIATRIS™ is a new kind of global healthcare company formed in 2020 through the combination of Mylan and Upjohn, a legacy division of Pfizer. By integrating the strengths of these two companies, including our global workforce of approximately ~45,000, we aim to deliver increased access to affordable, quality medicines for patients worldwide, regardless of geography or circumstance.
  • Number of Employees: 5K-10K
  • Annual Revenue: > $1 Billion
  • www.viatris.com
  • Robert J. Coury Global Center 1000 Mylan Blvd.
    Canonsburg, PA USA 15317
  • Phone: 724.514.1800

Executives

Name Title Contact Details

Similar Companies

Hoveround

The company, founded in 1992 by former nurse and inventor Tom Kruse, is based in Sarasota, Florida.

Process HVAC Solutions

Process HVAC Solutions, LLC is a Belle Vernon, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Eisai

Eisai Inc. is a U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd., a research-based human health care (hhc) company that discovers, develops and markets products throughout the world.

TearClear

TearClear is an emerging ophthalmic pharmaceutical company with the goal of disrupting the way current topical medications are delivered to the ocular surface. Our lead product candidates in glaucoma will pave the way for future indications across multiple programs in development.

Santen

At Santen, we`re innovating therapies to improve the quality of life for patients worldwide. Our single focus in ophthalmology enables us to challenge unmet needs in the field—through passionate research, successful collaboration, and clarity of commitment. With over 120 years of investigative insight, Santen remains committed to the discovery, exploration, and development of ophthalmic therapies. Now, and into the future. As a global company, Santen is often expanding to accommodate new and evolving initiatives in ophthalmic research, regulatory management, production, marketing, or distribution. Our clinical development network now spans three continents, with centers in EMEA (Europe, the Middle East and Africa), Japan, and the United States.